CAS 923978-27-2
:2-[2,6-Dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methylpropanoic acid
Description:
2-[2,6-Dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methylpropanoic acid, with CAS number 923978-27-2, is a synthetic organic compound characterized by its complex structure, which includes multiple functional groups such as phenoxy, methylthio, and a propenoyl moiety. This compound is likely to exhibit properties typical of organic acids, including solubility in polar solvents and potential reactivity with bases. The presence of the methylthio group suggests possible applications in medicinal chemistry, as sulfur-containing compounds often exhibit unique biological activities. The compound's structure indicates it may interact with biological targets, potentially influencing pathways related to inflammation or cell signaling. Additionally, the presence of multiple methyl groups may enhance lipophilicity, affecting its pharmacokinetics and bioavailability. Overall, this compound's intricate design suggests it could be of interest in research and development within pharmaceutical and agrochemical fields, although specific biological activity and safety profiles would require further investigation.
Formula:C22H24O4S
InChI:InChI=1S/C22H24O4S/c1-14-12-16(13-15(2)20(14)26-22(3,4)21(24)25)6-11-19(23)17-7-9-18(27-5)10-8-17/h6-13H,1-5H3,(H,24,25)/b11-6+
InChI key:InChIKey=AFLFKFHDSCQHOL-IZZDOVSWSA-N
SMILES:O(C(C(O)=O)(C)C)C1=C(C)C=C(/C=C/C(=O)C2=CC=C(SC)C=C2)C=C1C
Synonyms:- Elafibranor
- 2-[2,6-Dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methylpropanoic acid
- GFT 505
- Propanoic acid, 2-[2,6-dimethyl-4-[(1E)-3-[4-(methylthio)phenyl]-3-oxo-1-propen-1-yl]phenoxy]-2-methyl-
- GFT-505
- Elafibranor(GFT505) ISO 9001:2015 REACH
- GFT505(ELAFIBRANOR)
- Elafibranor (GFT-505, Ph III)
- CS-2411
- (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid
- ELAFIBRANOR;GF T505;GFT-505;GFT505
- Elafibranor(GFT505)
- GFT505; GFT-505; GFT 505;
- SureCN815512
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
Ref: IN-DA00GUAU
1g318.00€5gTo inquire10gTo inquire25gTo inquire5mg70.00€10mg93.00€25mg122.00€100mg120.00€250mg178.00€(E)-2-(2,6-Dimethyl-4-(3-(4-(Methylthio)Phenyl)-3-Oxoprop-1-En-1-Yl)Phenoxy)-2-Methylpropanoic Acid
CAS:(E)-2-(2,6-Dimethyl-4-(3-(4-(Methylthio)Phenyl)-3-Oxoprop-1-En-1-Yl)Phenoxy)-2-Methylpropanoic AcidPurity:95%Molecular weight:384.49g/molElafibranor
CAS:<p>Elafibranor (GFT505) is an agonist of the peroxisome proliferator-activated receptor-α (PPAR-α) and peroxisome proliferator-activated receptor-δ (PPAR-δ) with</p>Formula:C22H24O4SPurity:98.42% - 98.78%Color and Shape:SolidMolecular weight:384.49Elafibranor
CAS:<p>Dual agonist of PPARα and PPARδ receptors</p>Formula:C22H24O4SPurity:Min. 98 Area-%Color and Shape:Yellow PowderMolecular weight:384.49 g/mol(E)-2-(2,6-Dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid
CAS:Formula:C22H24O4SPurity:98%Molecular weight:384.49GFT-505
CAS:Controlled Product<p>Stability Light Sensitive<br>Applications GFT-505 is a dual PPARα/δ agonist. Studies have shown that GFT-505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjects. It may also be a potential new drug candidate for treating lipid and glucose disorders.<br>References Carious, B., et al.: Diabetes Care 36, 2923 (2013); Carious, B., et al.: Diabetes Care 34, 2008 (2011)<br></p>Formula:C22H24O4SColor and Shape:NeatMolecular weight:384.49





